{"article_link": "https://doi.org/10.1038/s41591-021-01329-2", "data": [{"id": "data_1", "omics": "Transcriptomics", "link": "https://covid19cellatlas.org/", "format": "h5ad", "source": "ArrayExpress", "public_id": "E-MTAB-10026"}, {"id": "data_2", "omics": "Proteomics", "link": "https://covid19cellatlas.org/", "format": "Processed Data", "source": "Custom CITE-seq", "public_id": "E-MTAB-10026"}, {"id": "data_3", "omics": "Immunomics (TCR)", "link": "https://covid19cellatlas.org/", "format": "Processed Data", "source": "10x Genomics", "public_id": "E-MTAB-10026"}, {"id": "data_4", "omics": "Immunomics (BCR)", "link": "https://covid19cellatlas.org/", "format": "Processed Data", "source": "10x Genomics", "public_id": "E-MTAB-10026"}, {"id": "data_5", "omics": "Multi-omics", "link": "https://covid19cellatlas.org/", "format": "Processed Data", "source": "Combined Transcriptomics, Proteomics, and Immunomics", "public_id": "E-MTAB-10026"}], "analyses": [{"id": "analysis_1", "analysis_type": "single-cell transcriptome and surface proteome analysis", "analysis_data": ["data_1", "data_2"], "training_set": [], "test_set": [], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_2", "analysis_type": "cell clustering and annotation", "analysis_data": ["data_1", "data_2", "data_3", "data_4"], "training_set": [], "test_set": [], "label": {"condition": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_3", "analysis_type": "differential abundance testing", "analysis_data": ["data_1", "data_2", "data_3", "data_4"], "training_set": [], "test_set": [], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_4", "analysis_type": "gene set enrichment analysis (GSEA)", "analysis_data": ["data_1", "data_2", "data_3", "data_4"], "training_set": [], "test_set": [], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_5", "analysis_type": "cydar analysis", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_6", "analysis_type": "TCR clonality analysis", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_7", "analysis_type": "BCR clonality and mutation analysis", "analysis_data": ["data_4"], "training_set": [], "test_set": [], "label": {"gender": ["female", "male"], "severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_8", "analysis_type": "interferon, TNF, and JAK–STAT response scoring", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_9", "analysis_type": "kBET analysis", "analysis_data": ["data_1", "data_2"], "training_set": [], "test_set": [], "label": {"batch_factor": ["site"]}}, {"id": "analysis_10", "analysis_type": "bronchoalveolar lavage (BAL) data comparison", "analysis_data": ["data_1", "data_2"], "training_set": [], "test_set": [], "label": {"source": ["GSE145926"]}}, {"id": "analysis_11", "analysis_type": "cellphonedb receptor-ligand interaction analysis", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"cell_type": ["monocytes", "platelets"]}}, {"id": "analysis_12", "analysis_type": "platelet activation analysis", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"condition": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_13", "analysis_type": "HSPC commitment scoring", "analysis_data": ["data_1", "data_2"], "training_set": [], "test_set": [], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_14", "analysis_type": "multiplex cytokine analysis", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_15", "analysis_type": "restimulation of pbmcs with sars-cov-2 peptide", "analysis_data": ["data_1", "data_2", "data_3"], "training_set": [], "test_set": [], "label": {"condition": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_16", "analysis_type": "flow cytometry validation", "analysis_data": ["data_1", "data_2", "data_3"], "training_set": [], "test_set": [], "label": {"condition": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}, {"id": "analysis_17", "analysis_type": "differential correlation analysis", "analysis_data": ["data_1", "data_2"], "training_set": [], "test_set": [], "label": {"severity": ["healthy", "asymptomatic", "mild", "moderate", "severe", "critical"]}}], "results": [{"analysis_id": "analysis_1", "metric": "fold change", "value": "~200,000 cells per donor", "features": ["CD14+ monocytes", "CD16+ monocytes", "plasmablasts", "B cells", "CD8+ T cells", "CD4+ T cells", "NK cells", "HSPCs"]}, {"analysis_id": "analysis_2", "metric": "clustering resolution", "value": "18 cell subsets and 27 cell states identified", "features": ["18 cell subsets", "27 cell states", "proliferating monocytes", "innate lymphoid cell subpopulations", "isotype-specific plasma cells"]}, {"analysis_id": "analysis_3", "metric": "fold change", "value": "1.81 (odds ratio for CD8+ T cell clonality), 0.87 (odds ratio for CD8+ TEM cells)", "features": ["CD8+ T cells", "CD8+ TEM cells", "plasmablasts", "plasma cells"]}, {"analysis_id": "analysis_4", "metric": "", "value": "", "features": ["IL-2–STAT5 signaling", "mTORC1 signaling", "inflammatory response", "IFNγ response", "IL-6–JAK–STAT3 signaling"]}, {"analysis_id": "analysis_5", "metric": "spatial FDR", "value": "<0.05", "features": ["608 hyperspheres", "B cells", "plasma cells", "HSPCs"]}, {"analysis_id": "analysis_6", "metric": "odds ratio", "value": "1.81 (CD8+ T cells), 0.87 (CD8+ TEM cells)", "features": ["CD8+ T cells", "CD8+ TEM cells", "TE:EM ratio"]}, {"analysis_id": "analysis_7", "metric": "clonotype size gini index", "value": "disproportionate clonotype size distribution", "features": ["IGHV1-46 gene usage in women with critical disease", "clonotype size gini indices", "node closeness centrality"]}, {"analysis_id": "analysis_8", "metric": "normalized enrichment score (NES)", "value": "0.75", "features": ["type I/III IFN response", "TNF signaling", "JAK–STAT response"]}, {"analysis_id": "analysis_9", "metric": "wilcoxon paired signed-rank test", "value": "P < 2.1 × 10⁻⁸", "features": ["improved rejection rate after integration", "mixing of cells by site"]}, {"analysis_id": "analysis_10", "metric": "", "value": "", "features": ["similarity between CD16+ monocytes and BAL macrophages", "expression of FCGR3A", "C1QA/B/C", "type I IFN response genes"]}, {"analysis_id": "analysis_11", "metric": "", "value": "", "features": ["SIRPA:CD47", "FPR1:ANXA1", "FPR2:APP", "ICAM1 interactions"]}, {"analysis_id": "analysis_12", "metric": "", "value": "", "features": ["platelet activation markers", "PF4", "GP9", "STXBP2", "CD34+ HSPCs"]}, {"analysis_id": "analysis_13", "metric": "ANOVA with Tukey’s test", "value": "P = 2.92 × 10⁻¹⁸ (TE:EM ratio)", "features": ["TE:EM ratio", "CD8+ T cell differentiation", "CD8+ TTE", "CD8+ TEM"]}, {"analysis_id": "analysis_14", "metric": "", "value": "", "features": ["CCL4", "CXCL10", "IL-7", "IL-1α"]}, {"analysis_id": "analysis_15", "metric": "fold change", "value": "0.0051", "features": ["CD137", "CD107a", "CD8+ T cell activation"]}, {"analysis_id": "analysis_16", "metric": "percentage of cells", "value": "50,000–60,000 cells per pool", "features": ["CD137", "CD107a", "CD8+ T cell activation"]}, {"analysis_id": "analysis_17", "metric": "pearson correlation", "value": "0.8", "features": ["TFH and plasmablast/plasma cell correlation", "loss in severe disease"]}]}